Results 111 to 120 of about 32,822 (166)

Efficacy of dual antiplatelet therapy for three months versus 12 months after coronary artery bypass grafting: multicentre, double blinded, randomised controlled trial.

open access: yesBMJ
Yuan X   +27 more
europepmc   +1 more source

Dual antiplatelet therapy in the ‘real world’

Heart, 2018
Dual antiplatelet therapy (DAPT) with aspirin and an oral P2Y12 inhibitor is a successful strategy for preventing recurrent ischaemic events following acute coronary syndromes (ACS). Clopidogrel was previously the P2Y12 inhibitor of choice but interpatient heterogeneity in levels of achieved platelet inhibition and delayed onset of action limit its ...
Eunice N C, Onwordi   +2 more
openaire   +2 more sources

Exodontia in dual antiplatelet therapy: the evidence

British Dental Journal, 2016
Haemostasis is crucial for the success of oral surgical treatment as bleeding problems can cause complications both pre- and post-operatively. Patients on antiplatelet drugs present a challenge due to their increased risk of bleeding.To identify a protocol for the management of oral surgery patients on dual antiplatelet therapy (aspirin and clopidogrel)
S, Nathwani, K, Martin
openaire   +2 more sources

Dual antiplatelet therapy duration

Current Opinion in Cardiology, 2011
To address the evidence, or lack thereof, of dual antiplatelet therapy (DAPT) duration in the percutaneous coronary intervention (PCI) setting.The most recent guidelines on DAPT in the PCI setting are rather discordant about the duration of therapy and refer to results of studies which are often controversial.
Giuseppe, Musumeci   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy